Chemotargets enters a new phase of growth - from a software company to a drug discovery biotech.

Chemotargets enters a new phase of growth -  from a software company to a drug discovery biotech. - Main Image

This public-private partnership will establish a framework for collaboration that promotes the creation of synergies between both institutions.

Chemotargets has entered into a strategic alliance with the IMIM Hospital del Mar Medical Research Institute to accelerate the design of new cancer therapies. This alliance will allow Chemotargets to build an oncology pipeline with biologically relevant and therapeutically validated targets at IMIM.

More information here.